Diagnosed cases of chronic heart failure are expected to number 32 million by 2028, according to a report from analytics company GlobalData.

Updated screening technologies and more widespread use of statins have rendered aspirin ineffective for the primary prevention of CVD, according to a study published in Family Practice.

Results from the National Youth Tobacco Survey, released Dec. 5 by the CDC, reveal that 6.2 million middle- and high-school students have used a tobacco product in the past month.

Patients with atrial fibrillation may be more likely to stick to a regimen of oral anticoagulation if they’re first prescribed OACs in the emergency department, according to a study published Dec. 9 in the Canadian Medical Association Journal. 

Smoking e-cigarettes could have potentially deleterious effects on a person’s mental health, according to a JAMA Network Open study that solidified a link between vaping and self-reported clinical depression.

A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

The FDA is testing metformin, a popular drug used to treat type 2 diabetes, for carcinogenic impurities.

Beta-blocker use was linked to an increased risk of heart failure hospitalizations in a recent study of patients with “stiff heart” HF—a concerning finding considering the majority of such patients take the drugs as part of their care regimen.